CXCL8 and cancer: IL-8 is correlated with tumour burden in xenograft models, and in patients with several cancer types.37 IL-8 could be an effective marker of early response to immunotherapy.38 Pharmaceutical agents inhibiting IL-8 may be a therapeutic option for targeting the tumour microenvironment.